JW Holdings Corporation (KRX:096760)
3,050.00
+20.00 (0.66%)
Feb 21, 2025, 9:00 AM KST
JW Holdings Revenue
JW Holdings had revenue of 226.49B KRW in the quarter ending September 30, 2024, with 4.61% growth. This brings the company's revenue in the last twelve months to 925.73B, up 2.01% year-over-year. In the year 2023, JW Holdings had annual revenue of 928.07B with 7.35% growth.
Revenue (ttm)
925.73B
Revenue Growth
+2.01%
P/S Ratio
0.24
Revenue / Employee
6.81B
Employees
136
Market Cap
215.72B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 928.07B | 63.54B | 7.35% |
Dec 31, 2022 | 864.54B | 75.60B | 9.58% |
Dec 31, 2021 | 788.94B | 7.42B | 0.95% |
Dec 31, 2020 | 781.51B | 53.43B | 7.34% |
Dec 31, 2019 | 728.08B | 2.70B | 0.37% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
Yuhan | 2,008.84B |
SK Biopharmaceuticals | 511.33B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Peptron | 2.41B |
Hanall Biopharma | 134.24B |